Related Experiment Videos
In vitro susceptibility of Ureaplasma urealyticum to rosaramicin
Antimicrobial Agents and Chemotherapy
|July 1, 1979
Abstract:
Thirty-two clinical isolates of Ureaplasma urealyticum were inhibited by 0.036 mug of rosaramicin per ml, whereas 25 (78%) and 13 (41%) of the strains were inhibited by this concentration of minocycline and tetracycline, respectively. These results suggest that rosaramicin may be useful for the treatment of U. urealyticum infections.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A Rapid Review of International Evaluations of interRAI Systems.
Healthcare management forum·2025
Radiative transfer for a three-dimensional raining cloud.
Applied optics·2010
Real-time PCR in clinical microbiology: applications for routine laboratory testing.
Clinical microbiology reviews·2006
Comparative adjuvant therapy to reduce vancomycin-associated nephrotoxicity in an animal model.
Antimicrobial agents and chemotherapy·2026
Repeated emergence and fitness heterogeneity of KPC-33 in ST11 Klebsiella pneumoniae under ceftazidime-avibactam pressure.
Antimicrobial agents and chemotherapy·2026
Rapid broad-spectrum activity of molecular iodine against multidrug-resistant bacterial and fungal pathogens without residual staining.
Antimicrobial agents and chemotherapy·2026
Functional validation of the Plasmodium falciparum K13 C580Y mutation in recently collected Ethiopian isolates.
Antimicrobial agents and chemotherapy·2026
The spiral evolution of techniques for the laboratory diagnosis of microbial infections.
Frontiers in cellular and infection microbiology·2026
Dynamics of the gut microbiome and metabolome in children during and after an infectious diarrheal episode.
Frontiers in cellular and infection microbiology·2026
Real-world pathogen spectrum, clinical actionability, and host correlates of first-time mNGS testing in hospitalized patients with hematologic diseases.
Frontiers in cellular and infection microbiology·2026